Skip to content
Home/Companies/Pharma/Theravia
Theravia

Theravia

Pharma·Europe·Exited 2025·Held 7yr
Entry
2018
Hold
7yr
Exit
2025

Who owns Theravia?

Theravia is a Pharma company based in Europe, now owned by Norgine, which acquired it in 2025 from Merieux Equity Partners.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Merieux Equity Partners
Investor
Merieux Equity Partners
Mérieux Participations 2 · 2014 · Buyout

Key facts

HQEurope
SectorPharma
StatusActive
Websitewww.theravia.com
Exit Type
Trade Sale
Buyer
Norgine
Exit Year
2025

More from Mérieux Participations 2

Other portfolio companies in the same fund.

Nutragroup
Nutragroup
Active
HealthcareFrance· 2018
SGH Medical Pharma
SGH Medical Pharma
Active
PharmaBelgium· 2018
Laboratoires INELDEA
Laboratoires INELDEA
Exited 2021
HealthcareFrance· 2017
to ICG
LNA Santé
Exited 2022
HealthcareFrance· 2016
to Siparex / Unexo / Sodero Gestion
Seqens
Seqens
Active
PharmaFrance· 2016
KeepMED
Exited
MedTechIsrael· 2015

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Theravia?

Theravia is now owned by Norgine, which acquired it in 2025 from Merieux Equity Partners.

When did Norgine acquire Theravia?

Norgine acquired Theravia in 2025, buying from Merieux Equity Partners.

Who did Theravia sell to?

Merieux Equity Partners sold Theravia to Norgine in 2025 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue